Drug Profile
Research programme: 13-valent and 23-valent pneumococcal vaccines - Chongqing Zhifei Biological Products
Alternative Names: 13-valent pneumococcal conjugate vaccine; 23-valent pneumococcal polysaccharide vaccineLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Chongqing Zhifei Biological Products
- Class Conjugate vaccines; Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Pneumococcal-infections in China (Parenteral, Injection)
- 29 Oct 2012 Preclinical trials in Pneumococcal infections in China (Parenteral)